Management of Adult Leydig-Cell Testicular Tumors: Assessing the Role of Laparoscopic Retroperitoneal Lymph Node Dissection

2003 ◽  
Vol 17 (9) ◽  
pp. 777-780 ◽  
Author(s):  
Reinhard Peschel ◽  
Matthew T. Gettman ◽  
Hannes Steiner ◽  
Richard Neururer ◽  
Georg Bartsch
1996 ◽  
Vol 63 (1_suppl) ◽  
pp. 84-87
Author(s):  
F. Di Tonno ◽  
G. D'INCà ◽  
R. Bertoldin ◽  
F. Vianello ◽  
R. Di Pietro ◽  
...  

Leydig Cell Tumours (LCT) account for 3% of all testicular tumours; 10% are malignant and are refractory to radio- and chemotherapy. The role of Retroperitoneal Lymph Node Dissection in clinical stage I LCT is therefore a particularly debated one. From March ‘83 to December ‘95, 10 patients with LCT were subjected to orchiectomy (1 of them bilaterally because of a metachronous tumour). In 10 out of 11 specimens the following pathological features – a) size larger than 50 mm, b) infiltration of spermatic cord, c) lymphatics and veins, d) capsule, e) necrosis, f) cellular pleomorphism, g) numerous mitoses, h) nuclear atypia – were absent. The only patient in which b) and d) were present was subjected to RPLND. After a follow-up ranging from 17 to 157 months all patients are disease-free. Abstention from RPLND in clinical stage I LCT therefore seems the more rational choice when the above- listed pathologic features are absent.


Cancer ◽  
2003 ◽  
Vol 98 (4) ◽  
pp. 753-757 ◽  
Author(s):  
Ashraf A. Mosharafa ◽  
Richard S. Foster ◽  
Richard Bihrle ◽  
Michael O. Koch ◽  
Thomas M. Ulbright ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document